BEVACIZUMAB AND FOTEMUSTINE FOR RECURRENT HIGH GRADE GLIOMAS

被引：0
|
作者：
Sponghini, A. P. [1 ]
Platini, F. [1 ]
Rondonotti, D. [1 ]
Trevisan, E. [2 ,3 ]
Soffietti, R. [2 ,3 ]
机构：
[1] AOU Maggiore della Carita, SC Oncol, Novara, Italy
[2] Univ Turin, Dept Neurooncol, Turin, Italy
[3] Hosp Turin, City Hlth & Sci, Turin, Italy
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu330.18
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
431P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Salvage therapy with bevacizumab and fotemustine in recurrent high grade gliomas
    Trevisan, E.
    Picco, E.
    Ruda, R.
    Crasto, S. Greco
    Fabrini, M. G.
    Scotti, V.
    Caroli, M.
    Lolli, I.
    Guarneri, D.
    Soffietti, R.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 499 - 499
  • [2] SALVAGE THERAPY WITH BEVACIZUMAB AND FOTEMUSTINE IN RECURRENT HIGH GRADE GLIOMAS
    Ruda, Roberta
    Trevisan, Elisa
    Picco, Elisabetta
    Crasto, Stefania Greco
    Fabrini, Maria Grazia
    Scotti, Valerio
    Caroli, Manuela
    Lolli, Ivan
    Guarneri, Daniele
    Soffietti, Riccardo
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [3] Salvage therapy with bevacizumab and chemotherapy (irinotecan or fotemustine) in recurrent high-grade gliomas
    Trevisan, E.
    Laguzzi, E.
    Picco, E.
    Ruda, R.
    Crasto, S. Greco
    Gaidolfi, E.
    Fabrini, M. G.
    Scotti, V.
    Caroli, M.
    Bazzoli, E.
    Guarneri, D.
    Soffietti, R.
    [J]. JOURNAL OF NEUROLOGY, 2009, 256 : S53 - S53
  • [4] Salvage therapy with bevacizumab and fotemustine in recurrent high grade gliomas: an Italian multicentre study
    Trevisan, E.
    Ruda, R.
    Picco, E.
    Crasto, S. Greco
    Gaidolfi, E.
    Fabrini, M. G.
    Scotti, V.
    Lolli, I.
    Caroli, M.
    Guarneri, D.
    Soffietti, R.
    [J]. JOURNAL OF NEUROLOGY, 2010, 257 : S48 - S48
  • [5] BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMAS
    Sahebjam, Solmaz
    Garoufalis, Evgenia
    Guiot, Marie Christine
    Muanza, Thierry
    Del Maestro, Ronaldo
    Kavan, Petr
    [J]. NEURO-ONCOLOGY, 2010, 12 : 43 - 43
  • [6] Bevacizumab for patients with recurrent high grade gliomas
    Gilbert, Mark R.
    [J]. CANCER INVESTIGATION, 2007, 25 : 1 - 1
  • [7] Bevacizumab in recurrent high-grade pediatric gliomas
    Narayana, Ashwatha
    Kunnakkat, Saroj
    Chacko-Mathew, Jeena
    Gardner, Sharon
    Karajannis, Matthias
    Raza, Shahzad
    Wisoff, Jeffrey
    Weiner, Howard
    Harter, David
    Allen, Jeffrey
    [J]. NEURO-ONCOLOGY, 2010, 12 (09) : 985 - 990
  • [8] Activity and Safety of Bevacizumab Plus Fotemustine for Recurrent Malignant Gliomas
    Vaccaro, V.
    Fabi, A.
    Vidiri, A.
    Giannarelli, D.
    Metro, G.
    Telera, S.
    Vari, S.
    Piludu, F.
    Carosi, M. A.
    Villani, V.
    Cognetti, F.
    Pompili, A.
    Marucci, L.
    Carapella, C. M.
    Pace, A.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [9] An Overview of Fotemustine in High-Grade Gliomas: From Single Agent to Association with Bevacizumab
    Lombardi, Giuseppe
    Farina, Patrizia
    Della Puppa, Alessandro
    Cecchin, Diego
    Pambuku, Ardi
    Bellu, Luisa
    Zagonel, Vittorina
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [10] ACTIVITY AND SAFETY OF THE COMBINATION BEVACIZUMAB AND FOTEMUSTINE IN RECURRENT MALIGNANT GLIOMAS
    Fabi, Alessandra
    Villani, Veronica
    Vaccaro, Vanja
    Vidiri, Antonello
    Giannarelli, Diana
    Piludu, Francesca
    Anelli, Vincenzo
    Carapella, Carmine
    Cognetti, Francesco
    Pace, Andandrea
    [J]. NEURO-ONCOLOGY, 2013, 15 : 108 - 108
12345